NVOH
Novo Nordisk A/S (B Shares) ADRhedged
Price Chart
Latest Quote
$22.03
-0.04 (-0.18%)
Current Price
| Previous Close | $22.07 |
| Open | $22.03 |
| Day High | $22.03 |
| Day Low | $22.03 |
| Volume | 141 |
Fund Information
| Quarterly Dividend / Yield | N/A / 7.37% |
| Net Assets | $3.60M |
| Expense Ratio | 0.19% |
| Category | Health |
| Fund Family | ADRH |
| Net Asset Value | $22.14 |
| Premium/Discount | -0.49% |
| Quarterly Dividend Yield | 7.37% |
| P/E Ratio | 9.86 |
| Exchange | PCX |
📊 ETF Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
Analyst Data
Technical Indicators
| SMA20 | $21.67 |
| SMA50 | $23.00 |
| SMA200 | $23.81 |
| RSI | 58.98 |
| ATR | 0.3830 |
| Rel Volume | 0.12 |
Performance History
| Week | -0.31% |
| Month | +2.34% |
| Quarter | -21.10% |
| 6 Months | +0.64% |
| YTD | -18.32% |
| Year | -19.20% |
| 10 Years | -52.05% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-27 | $22.03 | 141 |
| 2026-10-26 | $22.07 | 600 |
| 2026-10-23 | $22.02 | 500 |
| 2026-10-22 | $22.23 | 1,200 |
| 2026-10-21 | $21.99 | 800 |
| 2026-10-20 | $22.10 | 1,300 |
| 2026-10-19 | $21.67 | 600 |
| 2026-10-16 | $21.80 | 500 |
| 2026-10-15 | $22.08 | 1,900 |
| 2026-10-14 | $21.62 | 1,200 |
| 2026-10-13 | $21.53 | 400 |
| 2026-10-12 | $21.73 | 400 |
| 2026-10-09 | $21.79 | 100 |
| 2026-10-08 | $21.67 | 6,000 |
| 2026-10-07 | $21.58 | 2,900 |
| 2026-10-06 | $21.08 | 400 |
| 2026-10-05 | $21.19 | 900 |
| 2026-10-02 | $20.99 | 900 |
| 2026-10-01 | $21.07 | 500 |
| 2026-09-30 | $21.21 | 1,900 |
| 2026-09-29 | $21.38 | 800 |
| 2026-09-28 | $21.53 | 700 |
About Novo Nordisk A/S (B Shares) ADRhedged
The series, under normal circumstances, invests at least 95% of its net assets in American Depositary Receipts (“ADRs”) of the Novo Nordisk A/S (B Shares) (the “Company”). The series will not invest directly in the company. The fund is non-diversified.
📰 Latest News
No news articles available at the moment. Check back later for updates on NVOH.
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.